A recent study found that high cannabis usage in colon cancer patients may experience increased mortality.
Image | adobe.stock/Pormezz
According to a recent study conducted by the University of California San Diego School of Medicine (San Diego, California), researchers saw that colon cancer patients who had a documented history of high cannabis use “were more than 20 times more likely to die within five years of diagnosis compared to those without such a history,” (1,2).
“This study adds to a growing body of evidence suggesting that heavy cannabis use may have underrecognized impacts on the immune system, mental health and treatment behaviors — all of which could influence cancer outcomes,” lead author Raphael Cuomo, Ph.D., associate professor in the Department of Anesthesiology at UC San Diego School of Medicine and a member of UC San Diego Moore’s Cancer Center, commented (1).
To gather data, researchers gathered and analyzed more than 1,000 colon cancer patients electronic health records that received treatment in the University of California Health system between 2012 to 2024 (1,2). With these records, the cancer outcomes of these patients were reviewed on “patients’ documented cannabis use before diagnosis, controlling for age, sex and indicators of disease severity such as tumor staging and cancer biomarkers,” (1).
UC San Diego Today reported that the analysis found (1):
“High cannabis use is often associated with depression, anxiety and other challenges that may compromise a patient’s ability to engage fully with cancer treatment,” Cuomo said (1). “However, this isn’t about vilifying cannabis. It’s about understanding the full range of its impacts, especially for people facing serious illnesses. We hope these findings encourage more research — and more nuanced conversations — about how cannabis interacts with cancer biology and care.”
References
Best of the Week: June 13 – June 19, 2025
June 20th 2025Here, we bring you our top five recent articles covering medical cannabis in Hawaii, a new dispensary in Connecticut, pesticide testing in California, a cease-and-desist letter to a dispensary on Long Island, and a global survey on cannabis for endometriosis.
Global Survey Examines Cannabis Use over Pharmaceuticals for Endometriosis Symptom Relief
June 17th 2025A survey of nearly 900 endometriosis patients across 28 countries highlights cannabis as a preferred alternative to pharmaceuticals, despite legal, social, and medical communication barriers.
Best of the Week: June 6 – June 12, 2025
June 13th 2025Here, we bring you our top five recent articles covering safety regulations in North Carolina, licenses in Minnesota, the FDA’s FY2026 Agriculture appropriations bill, cannabis taxes in California, and antifungal properties of CBD and CBDV.